Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epileptic Hippocampus in Alzheimer's Disease
NCT05899764Phase 2Not yet recruiting
- Sponsor
- University of California, Los Angeles
- Start
- Jan 2026
- Primary completion
- Jun 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of brivaracetam in Alzheimer's disease (AD), Mild Cognitive Impairment (MCI), sponsored by University of California, Los Angeles. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
brivaracetam
03
Conditions
Alzheimer's disease (AD)Mild Cognitive Impairment (MCI)
Beyond the preview
Go deeper on NCT05899764.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05899764.